COVID-19: BMC starts second phase of sero-survey in Mumbai

By: |
Updated: Aug 10, 2020 3:05 PM

The survey will cover F-North (Dadar, Matunga and Dharavi), M-West (Deonar and Govandi) and R-North (Dahisar) wards, where a similar study was conducted last month, a Brihanmumbai Municipal Corporation (BMC) official said.

COVID-19, COVID-19 cases in mumbai, COVID-19 sero survey in mumbai,NITI Aayog, blood serum test, covid 19 death cases in mumbai, latest news on coronavirus cases in mumbaiThe serological surveillance for SARS-CoV2 infection has been jointly commissioned by the NITI Aayog, the BMC and the Tata Institute of Fundamental Research (TIFR). (IE photo)

The Mumbai civic body has started the second phase of sero-surveillance study in the city from Monday to assess the spread of COVID-19 and how many people have developed antibodies against the disease.

The survey will cover F-North (Dadar, Matunga and Dharavi), M-West (Deonar and Govandi) and R-North (Dahisar) wards, where a similar study was conducted last month, a Brihanmumbai Municipal Corporation (BMC) official said.

The study will provide information about the spread of the infection and also throw light on herd immunity, he said.

“The sero-surveillance study will give an insight into the spread of COVID-19 and development of antibodies. The paper work for the survey has begun from today,” Additional Municipal Commissioner Suresh Kakani said.

If everything goes as per the plan, the survey is expected to be completed in 12 days, he said.

A serological survey involves testing of blood serum of individuals to check for the prevalence of antibodies against an infection.

The sero survey conducted in the first half of July revealed that 57 per cent of slum population and 16 per cent of non-slum residents in the three civic wards had developed antibodies. It showed high proportion of asymptomatic COVID-19 infection in the city.

During the study last month, 6,936 samples out of an estimated 8,870 were collected from slum and non-slum population of the three civic wards.

The serological surveillance for SARS-CoV2 infection has been jointly commissioned by the NITI Aayog, the BMC and the Tata Institute of Fundamental Research (TIFR).

The study is being carried out in collaboration with organisations like the Kasturba Molecular Diagnostic Laboratory, Translational Health Science and Technology Institute (THSTI), A T E Chandra Foundation and IDFC Institute.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Delhi records over 40 COVID-19 deaths for second straight day; cases rise to 2,71,114
2COVID-19: Kerala witnesses highest single-day spurt of 7,445 new cases; total cases rise to 1.74 lakh
3ICMR’s 2nd sero-survey shows Indians far from achieving herd immunity against COVID-19: Harsh Vardhan